Pierre E. Queiroz de Oliveira

Pierre E. Queiroz de Oliveira

Registered Patent Attorney

Pittsburgh, PA
Phone: 412.454.5878    Fax: 412.454.5060


Dr. Queiroz de Oliveira has a wide array of technological experience and knowledge from his time spent as a researcher, as well as a patent attorney, including pharmacology, molecular biology, biochemistry, organic chemistry, pharmaceuticals, drug development and diagnostics.

Specific examples of Dr. Queiroz de Oliveira’s experience include:

  • advising companies on the creation and expansion of exclusivity strategies to protect therapeutic products through the interplay of patents, regulatory data and marketing exclusivity, trade secrets and other proprietary rights
  • conducting IP due diligence reviews and audits on behalf of pharmaceutical, biopharmaceutical, investors and lenders in preparation for partnering, financing and public offerings
  • providing counsel on and preparing nondisclosure agreements, consulting agreements, license agreements and collaboration/joint venture agreements for biotechnology companies
  • providing assistance to venture capital and investment funds in evaluating potential investment opportunities with biotechnology and pharmaceutical companies in relation to private placements/public financing transactions
  • preparing and filing patent applications and securing patents for pharmaceuticals, diagnostics, biologics and medical devices including formulation, delivery and combinatorial technologies
  • providing counsel on patent issues relating to product and technology development including analysis of patent coverage and infringement issues.


  • J.D., Duquesne University School of Law, 2014
  • Ph.D., Molecular Pharmacology, University of Pittsburgh School of Medicine, 2009
  • M.S., Pharmacology, with honors, University of Bath (United Kingdom), 2002

Bar Admissions

  • Pennsylvania
  • U.S. Patent and Trademark Office

Court Admissions

  • U.S. District Court, Western District of Pennsylvania

Practice Areas

Data protection laws have changed, so we have revised our Privacy Policy.